The Frontiers in Aging 2026 review classified CJC-1295 and Ipamorelin in a regulatory grey zone
Diabetes, Obesity & Metabolism, 22 (10), 18861891
Quick Answer: Weight gain on tirzepatide can occur due to fluid retention, metabolic adaptation, inadequate dosing, medication interactions, lifestyle factors, or underlying medical conditions that counteract the medication's appetite-suppressing effects
Our medical weight loss program uses a medication initially used to treat type 2 diabetes
"The industry has been actively engaged in initiatives to improve nutritional information accessibility for over a decade," Gallo said
Unusual reactions, like an allergy, rarely happen but can, and that is why monitoring with a doctor is important